Skip to main content

U.S. News & World Report: Good news, bad news on levodopa for parkinson’s disease

The most potent drug available for Parkinson’s disease, levodopa, treats symptoms of the disease but does nothing to either ease or increase its still-mysterious underlying causes, a new clinical trial has concluded. Doctors often delay prescribing levodopa, or L-dopa, to Parkinson’s patients for fear that the drug might have toxic effects that produce jerky involuntary body movements over time. (January 23, 2019)

Read the full article here



from Brain Health Daily http://bit.ly/2S70bN5

Comments

Popular posts from this blog

Reading Minds to Understand Human Tool Use

Combining brain imaging data with machine learning, researchers make new discoveries about how the brain controls the hand. The findings could lead to the development of more advanced neuroprosthetics. from Neuroscience News https://ift.tt/3tv7BbC

Rethinking the Link Between Cannabinoids and Learning

Disrupted cannabinoid signaling impairs learning by altering behavioral states. from Neuroscience News https://ift.tt/2Hrmr0g